Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib and capecitabine in solid tumors and breast cancer
NCT00959946Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Sep 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of bosutinib in breast cancer, pancreatic cancer (PC), colorectal cancer (CRC), cholangiocarcinoma (CCA), glioblastoma multiforme (GBM), sponsored by Pfizer. Started Sep 2009; status: terminated.
02
Drugs
bosutinib
03
Conditions
breast cancerpancreatic cancer (PC)colorectal cancer (CRC)cholangiocarcinoma (CCA)glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00959946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959946.